We observed downregulation of hepatic SLC27A5 mRNA expression in patients with NAFLD coupled with fibrosis, non‐alcoholic steatohepatitis (NASH) with fibrosis, and cirrhosis, as displayed in Figure1A. This evidence concerns the gene SLC27A5 and fibrosis.